Home
    Registration
    Accommodation
    Mailing List
    Contact us
     Home
     Welcome Note
     Committees
     Industry Advisory Board (IAB)
     Timetable
     Preliminary Scientific Program
     Abstract Submission
     Registration
     Accommodation
     Sponsorship & Exhibition
     General Information
         Entry Visas
     Past Congresses
     CODHy 2008 Webcasting
     Partners
     Links
     Contact us
The 1st Asia Pacific Congress on
Controversies to Consensus in Diabetes, Obesity and Hypertension (CODHy)
Shanghai, China, June 2-5, 2011
 
  Friday, June 3, 2011 Print

HALL A

 
08:30-10:00
Plenary Session 1
FUTURE THERAPY
Diabetes prevention vs. early diagnosis in Asia and worldwide
Metabolic benefits of incremental weight loss
Diabetes in Asia – Is it only the beta cell?
Recent trial to prevent CV disease: Is this the answer or has it created more questions?
    
 
10:30-12:30
Session 2
FIRST LINE THERAPY FOR T2D AFTER METFORMIN FOCUS ON ASIA
 
Glucosidan INH - First line therapy Vs. metformin
GLP1/DPP4 INH vs. Sulfonylurea / Insulin / TZDs
Pro / Con
       
 
13:30-15:30
Session 3
INSULIN THERAPY IN T2D
Initiation of insulin:
Not too early / Not too late
Combinations of Oral Hypoglycemic (OAD) with long-acting analogs
Place of TZD in Asian diabetic patients
               

16:00-17:30
Session 4
THERAPEUTIC APPROACH TO YOUTH WITH T2DM? IS IT EFFICIENT FOR ASIANS?
Insulin, metformin TZD, glucosidase INH
Combination therapy and lifestyle modifications 
        

HALL B

 
10:30-12:30
Session 5
TBA
  
      

13:30-15:30
Session 6
TREATMENT GOALS IN DIABETES
Should we aim to normalize A1c?
Pro / Con
The glucotriad: Is glucose variability a cardiovascular (CV) risk factor in its own right?
Pro / Con
                   
 
16:00-17:30
Session 7
PREVENTION AND TREATMENT OF DIABETIC NEPHROPATHY
Key role of glucose control:
Pro / Con
Key role of blood pressure (BP) control:
Pro / Con
Key role of lipid control:
Pro / Con
    

HALL C

 
10:30-12:30
Session 8
CARDIOMETABOLIC RISK ASSESSMENT AND METABOLIC SYNDROME CONTROVERSIES
     
    
  
13:30-15:30
Session 9
OPTIMIZING DIABETES THERAPY
Programmed insulin dose calculation:
Pro / Con   
Benefit of self-monitoring glucose control:
Pro / Con
Continuous glucose monitoring (CGM): For whom will it be beneficial? 
                            
  
16:00-17:30
Session 10
CARDIOVASCULAR RISK IN DIABETES FOCUS ON GENETICS IN ASIA
Hyperglycemia and CVD
Dyslipemia and CVD
Hypertension and CVD
Inflammation and CVD
Cultural obesity
         

Home    Contact Us   
Copyright © 2007 Comtecmed.com. All rights reserved.   The website was last updated on 02/09/2010 Created by    WebStudio.co.il